Table 6.
Costs and effectiveness over the next 10 years of SHHC for a national sample
| SHHC | Status Quo | Incremental of | ICERs from perspective of | ||
|---|---|---|---|---|---|
| SHHC−Status Quo | Healthcare | Society | |||
| Costs, $ | |||||
| Resource | 1,716,954,549 | 0 | 1,716,954,549 | √ | √ |
| Healthcare | 3,608,071,971 | 4,465,435,607 | −857,363,637 | √ | √ |
| Participant | 2,409,841,516 | 0 | 2,409,841,516 | √ | |
| Total | 7,734,868,036 | 4,465,435,607 | 3,269,432,429 | ||
| Health effects | |||||
| Heart events | 53,734 | 66,502 | −12,768 | ||
| Stroke events | 35,823 | 44,335 | −8512 | ||
| QALYs saved | 15,031,833 | 15,018,112 | 13,721 | 62,646 | 238,271 |
“√” indicates incremental costs used in ICER calculation under alternative perspectives. The heart events and stroke events are non-fatal events